Parkwood LLC Seagen Inc. Transaction History

Parkwood LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $17,235 - $19,454	-90 Reduced 1.05%	8,477 $1.8 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $760,129 - $835,518	-4,051 Reduced 32.1%	8,567 $1.65 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $7,145 - $11,372	56 Added 0.45%	12,618 $2.56 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $306,805 - $363,790	2,614 Added 26.28%	12,562 $1.61 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $56,137 - $74,745	-415 Reduced 4.0%	9,948 $1.36 Million

Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $508,142 - $837,471	-4,670 Reduced 31.06%	10,363 $10,000
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $55,499 - $73,242	464 Added 3.18%	15,033 $2.17 Million
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $1.03 Million - $1.38 Million	-7,217 Reduced 33.13%	14,569 $2.25 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $230,768 - $275,108	1,620 Added 8.03%	21,786 $3.7 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $308,117 - $367,469	-2,281 Reduced 10.16%	20,166 $3.18 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $1.31 Million - $1.81 Million	9,504 Added 73.43%	22,447 $3.12 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $2.13 Million - $2.74 Million	12,943 New	12,943 $2.27 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.